Prostate Cancer: Does PSA screening do more harm than good?doi:10.1038/nrurol.2009.63FarleySuzanne J.OAINature Reviews Urology
Comments on the controversial issue of prostate-specific antigen (PSA) screening for prostate cancer. Data on and possible explanations for the decline in the prostate cancer mortality rate in the U.S.; Reference to a study by the urology department of the University of Innsbruck, Austria that ...
Re: Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Singl... Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Un...
A number of potential mechanisms of action have been proposed to account for the cancer-preventive effects of tea and tea constituents (Figure 2). Among these are binding to and inhibition of specific high-affinity molecular targets, induction of oxidative stress, and enhancement of endogenous antio...
If your PSA is elevated, other tests may help decide if a biopsy is needed. If cancer is suspected, a biopsy can confirm it, and a wide range of approaches can be considered: from active surveillance (just monitoring the tests and seeing if the cancer grows), to zapping only the par...
- 《Cancer Causes Control》 被引量: 38发表: 2013年 Dosage du PSA, biopsie, cancer et hypertrophie bénigne de la prostate en France Prostate-specific antigen (PSA) testing is high in France. The aim of this study was to estimate their frequency and those of biopsy and newly diagnosed ca...
REALITY: Does any reasonable person think that a cure for cancer would remain secret for long? Obviously not. Now, let's think about this for a moment. Nurses get cancer. Pharmacists get cancer. Physicians get cancer, as do family members of these professionals. With the Internet and high-...
Analysis of five observa tional studies that had investigated statin use in relation to advanced prostate cancer did, however, indicate that these drugs might con fer a protective effect, although these stud ies did not control for potential differences in PSA testing among users and ...
nPSA is a strong independent predictor of freedom from PSA failure and PFS in patients with low and intermediate-risk localized prostate cancer treated with RT alone. Longer follow-up and larger patient numbers are required to confirm these observations. 展开 ...
However, test- ing total PSA (tPSA) levels to decide which patients should undergo a biopsy has been found to lead to high rates of false- negative and false-positive results. In men with false-negative results, cancer may be missed. Men with false-positive results may undergo unwarranted ...